Psychotomimetic effects of kappa opioid receptor agonists.
Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7365, USA.
Kate L
KL
White
Bryan L
BL
Roth
D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D019964:Mood Disorders / Q000188:drug therapy* / Q000378:metabolism; D009480:Neuropharmacology / Q000639:trends; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000378:metabolism; D011619:Psychotropic Drugs / Q000378:metabolism / Q000494:pharmacology; D017473:Receptors, Opioid, kappa / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects*
D011619:Psychotropic Drugs; D017473:Receptors, Opioid, kappa